Knowledge (XXG)

HPP+

Source 📝

1325: 31: 762:
Subramanyam B, Pond SM, Eyles DW, Whiteford HA, Fouda HG, Castagnoli N (December 1991). "Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol".
665:
Castagnoli N, Castagnoli KP, Van der Schyf CJ, Usuki E, Igarashi K, Steyn SJ, et al. (1999). "Enzyme-catalyzed bioactivation of cyclic tertiary amines to form potential neurotoxins".
651: 311: 63: 489:
HPP was first identified as a neurotoxic metabolite of haloperidol in 1990 and 1991, many years after haloperidol was introduced clinically and following the discovery of MPTP.
1370: 816: 46:
Haloperidol pyridinium; Haloperidol pyridinium ion; Haloperidol pyridinium cation; BCPP; 4-CFOBP; 4-(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)pyridinium
325: 692:
Subramanyam B, Rollema H, Woolf T, Castagnoli N (January 1990). "Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats".
1307: 727:
Subramanyam B, Woolf T, Castagnoli N (1991). "Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite".
1414: 1389: 1363: 1299: 546: 579:
Igarashi K (1998). "The Possible Role of an Active Metabolite Derived from the Neuroleptic Agent Haloperidol in Drug-Induced Parkinsonism".
1303: 809: 529:
Kostrzewa RM (2022). "Survey of Selective Monoaminergic Neurotoxins Targeting Dopaminergic, Noradrenergic, and Serotoninergic Neurons".
1429: 1419: 1394: 1356: 1202: 1050: 1007: 345: 474:(EPS) in patients undergoing long-term haloperidol therapy. An alternative theory posits that these symptoms result from long-term 1212: 1192: 870: 1409: 1103: 909: 846: 87: 1197: 802: 614:
Górska A, Marszałł M, Sloderbach A (October 2015). "" [The neurotoxicity of pyridinium metabolites of haloperidol].
1424: 1187: 1182: 1060: 353:
InChI=1S/C21H18ClFNO/c22-19-7-3-16(4-8-19)17-11-14-24(15-12-17)13-1-2-21(25)18-5-9-20(23)10-6-18/h3-12,14-15H,1-2,13H2/q+1
1279: 189: 1253: 1118: 1098: 1030: 841: 1232: 865: 825: 452: 376: 56: 417: 1093: 1157: 1133: 1128: 1113: 1040: 1035: 860: 471: 974: 851: 1295: 1291: 1287: 1227: 1143: 498: 448: 1108: 1404: 1222: 1152: 645: 1088: 1025: 238: 924: 1283: 1237: 1123: 420:
and has been detected in the brain following haloperidol administration in both animals and humans.
1332: 1138: 1045: 914: 399: 104: 904: 1399: 218: 780: 744: 709: 674: 633: 596: 542: 475: 441: 429: 1340: 178: 772: 736: 701: 623: 588: 534: 254: 113: 22: 1324: 1263: 1258: 502: 198: 1217: 1207: 1177: 959: 944: 402: 1336: 30: 1383: 1017: 982: 929: 878: 776: 705: 138: 1162: 833: 478: 456: 433: 538: 1167: 1065: 987: 934: 884: 396: 384: 1002: 874: 592: 380: 287: 169: 51: 628: 600: 1080: 794: 678: 637: 158: 784: 748: 713: 1070: 997: 992: 949: 919: 899: 149: 740: 894: 889: 124: 16:
Monoaminergic neurotoxin related to MPTP and metabolites of haloperidol
459: 451:-like symptoms in humans. HPP is a neurotoxin specifically affecting 409: 229: 964: 444: 1055: 954: 413: 406: 310: 301: 209: 969: 437: 798: 533:. Cham: Springer International Publishing. pp. 159–198. 1344: 1246: 1079: 1016: 832: 765:
Biochemical and Biophysical Research Communications
694:
Biochemical and Biophysical Research Communications
299: 286: 253: 248: 228: 208: 188: 168: 148: 123: 103: 78: 62: 50: 42: 37: 650:: CS1 maint: DOI inactive as of September 2024 ( 462:, and its neurotoxicity resembles that of MPTP. 333:C1=CC(=CC=C1C2=CC=(C=C2)CCCC(=O)C3=CC=C(C=C3)F)Cl 137: 524: 522: 520: 518: 112: 574: 572: 570: 568: 566: 564: 562: 560: 558: 1364: 810: 8: 21: 1371: 1357: 817: 803: 795: 177: 29: 627: 616:Postepy Higieny I Medycyny Doswiadczalnej 470:HPP may contribute to the development of 197: 395:HPP is formed from haloperidol, and its 514: 350: 330: 157: 92: 643: 20: 237: 217: 7: 1321: 1319: 581:Journal of Toxicology: Toxin Reviews 481:, rather than direct neurotoxicity. 128: 1343:. You can help Knowledge (XXG) by 14: 1323: 277: 274: 271: 265: 95:4--1-(4-fluorophenyl)butan-1-one 1308:Monoamine metabolism modulators 729:Chemical Research in Toxicology 505:, has been detected in humans. 358:Key:KAPIKUHBALFONG-UHFFFAOYSA-N 1415:Human pathological metabolites 1390:Drugs not assigned an ATC code 667:Polish Journal of Pharmacology 280: 259: 1: 1300:Monoamine reuptake inhibitors 1280:Receptor/signaling modulators 466:Extrapyramidal symptoms (EPS) 416:. The compound can cross the 777:10.1016/0006-291x(91)91228-5 706:10.1016/0006-291x(90)91936-m 539:10.1007/978-3-031-15080-7_53 501:metabolite of haloperidol, 1446: 1318: 1304:Monoamine releasing agents 249:Chemical and physical data 1430:Nervous system drug stubs 1420:Monoaminergic neurotoxins 1272: 826:Monoaminergic neurotoxins 593:10.3109/15569549809006488 531:Handbook of Neurotoxicity 341: 321: 83: 28: 1395:4-Fluorophenyl compounds 1335:article relating to the 629:10.5604/17322693.1175009 391:Formation and metabolism 377:monoaminergic neurotoxin 57:Monoaminergic neurotoxin 632:(inactive 2024-09-15). 472:extrapyramidal symptoms 1410:Human drug metabolites 493:Additional metabolites 373:haloperidol pyridinium 1203:MDMA (midomafetamine) 497:Besides HPP, another 1425:Pyridinium compounds 1066:Oxidopamine (6-OHDA) 988:Oxidopamine (6-OHDA) 978:-Methylnorsalsolinol 430:structurally related 1188:MDA (tenamfetamine) 1119:4-CAB (α-ethyl-PCA) 1061:MDA (tenamfetamine) 741:10.1021/tx00019a017 449:Parkinson's disease 418:blood–brain barrier 25: 856:-Cysteinyldopamine 1352: 1351: 1316: 1315: 1311: 1148:-Dimethyldopamine 1139:α-Me-DA (3,4-DHA) 548:978-3-031-15079-1 476:dopamine receptor 447:), which induces 442:active metabolite 432:to the selective 366: 365: 312:Interactive image 1437: 1373: 1366: 1359: 1327: 1320: 1274: 925:Dopamine quinone 819: 812: 805: 796: 789: 788: 759: 753: 752: 724: 718: 717: 689: 683: 682: 662: 656: 655: 649: 641: 631: 611: 605: 604: 576: 553: 552: 526: 479:supersensitivity 371:, also known as 314: 294: 282: 279: 276: 273: 267: 261: 241: 221: 201: 181: 161: 141: 131: 130: 116: 33: 26: 24: 1445: 1444: 1440: 1439: 1438: 1436: 1435: 1434: 1380: 1379: 1378: 1377: 1317: 1312: 1268: 1242: 1218:Norfenfluramine 1208:Methamphetamine 1075: 1012: 965:MPP (cyperquat) 960:Methamphetamine 871:ALDH inhibitors 828: 823: 793: 792: 761: 760: 756: 726: 725: 721: 691: 690: 686: 664: 663: 659: 642: 613: 612: 608: 578: 577: 556: 549: 528: 527: 516: 511: 495: 487: 468: 426: 393: 362: 359: 354: 349: 348: 337: 334: 329: 328: 317: 292: 270: 264: 244: 224: 204: 184: 164: 144: 127: 119: 99: 96: 91: 90: 74: 17: 12: 11: 5: 1443: 1441: 1433: 1432: 1427: 1422: 1417: 1412: 1407: 1402: 1397: 1392: 1382: 1381: 1376: 1375: 1368: 1361: 1353: 1350: 1349: 1337:nervous system 1328: 1314: 1313: 1273: 1270: 1269: 1267: 1266: 1261: 1256: 1250: 1248: 1244: 1243: 1241: 1240: 1235: 1230: 1225: 1220: 1215: 1210: 1205: 1200: 1195: 1190: 1185: 1180: 1175: 1170: 1165: 1160: 1155: 1150: 1141: 1136: 1131: 1126: 1121: 1116: 1111: 1106: 1101: 1096: 1091: 1085: 1083: 1077: 1076: 1074: 1073: 1068: 1063: 1058: 1053: 1048: 1043: 1038: 1033: 1028: 1022: 1020: 1014: 1013: 1011: 1010: 1005: 1000: 995: 990: 985: 980: 972: 967: 962: 957: 952: 947: 942: 937: 932: 927: 922: 917: 912: 907: 902: 897: 892: 887: 882: 868: 866:6-OHDA quinone 863: 858: 849: 844: 838: 836: 830: 829: 824: 822: 821: 814: 807: 799: 791: 790: 771:(2): 573–578. 754: 735:(1): 123–128. 719: 700:(1): 238–244. 684: 657: 606: 554: 547: 513: 512: 510: 507: 494: 491: 486: 483: 467: 464: 425: 422: 392: 389: 364: 363: 361: 360: 357: 355: 352: 344: 343: 342: 339: 338: 336: 335: 332: 324: 323: 322: 319: 318: 316: 315: 307: 305: 297: 296: 290: 284: 283: 268: 262: 257: 251: 250: 246: 245: 243: 242: 234: 232: 226: 225: 223: 222: 214: 212: 206: 205: 203: 202: 194: 192: 186: 185: 183: 182: 174: 172: 166: 165: 163: 162: 154: 152: 146: 145: 143: 142: 134: 132: 121: 120: 118: 117: 109: 107: 101: 100: 98: 97: 94: 86: 85: 84: 81: 80: 76: 75: 73: 72: 68: 66: 60: 59: 54: 48: 47: 44: 40: 39: 35: 34: 15: 13: 10: 9: 6: 4: 3: 2: 1442: 1431: 1428: 1426: 1423: 1421: 1418: 1416: 1413: 1411: 1408: 1406: 1403: 1401: 1398: 1396: 1393: 1391: 1388: 1387: 1385: 1374: 1369: 1367: 1362: 1360: 1355: 1354: 1348: 1346: 1342: 1338: 1334: 1329: 1326: 1322: 1310: 1309: 1305: 1301: 1297: 1296:Serotonergics 1293: 1292:Melatonergics 1289: 1288:Dopaminergics 1285: 1281: 1278: 1271: 1265: 1262: 1260: 1257: 1255: 1252: 1251: 1249: 1245: 1239: 1236: 1234: 1231: 1229: 1226: 1224: 1221: 1219: 1216: 1214: 1211: 1209: 1206: 1204: 1201: 1199: 1196: 1194: 1191: 1189: 1186: 1184: 1181: 1179: 1176: 1174: 1171: 1169: 1166: 1164: 1161: 1159: 1156: 1154: 1151: 1149: 1147: 1142: 1140: 1137: 1135: 1132: 1130: 1127: 1125: 1122: 1120: 1117: 1115: 1112: 1110: 1107: 1105: 1102: 1100: 1097: 1095: 1092: 1090: 1089:2'-Amino-MPTP 1087: 1086: 1084: 1082: 1078: 1072: 1069: 1067: 1064: 1062: 1059: 1057: 1054: 1052: 1049: 1047: 1046:6-Hydroxydopa 1044: 1042: 1039: 1037: 1034: 1032: 1029: 1027: 1026:2'-Amino-MPTP 1024: 1023: 1021: 1019: 1018:Noradrenergic 1015: 1009: 1006: 1004: 1001: 999: 996: 994: 991: 989: 986: 984: 983:Norsalsolinol 981: 979: 977: 973: 971: 968: 966: 963: 961: 958: 956: 953: 951: 948: 946: 943: 941: 938: 936: 933: 931: 930:Fenpropathrin 928: 926: 923: 921: 918: 916: 915:DOPAL quinone 913: 911: 908: 906: 903: 901: 898: 896: 893: 891: 888: 886: 883: 880: 879:methylmercury 876: 872: 869: 867: 864: 862: 859: 857: 855: 850: 848: 845: 843: 840: 839: 837: 835: 831: 827: 820: 815: 813: 808: 806: 801: 800: 797: 786: 782: 778: 774: 770: 766: 758: 755: 750: 746: 742: 738: 734: 730: 723: 720: 715: 711: 707: 703: 699: 695: 688: 685: 680: 676: 672: 668: 661: 658: 653: 647: 639: 635: 630: 625: 622:: 1169–1175. 621: 618:(in Polish). 617: 610: 607: 602: 598: 594: 590: 586: 582: 575: 573: 571: 569: 567: 565: 563: 561: 559: 555: 550: 544: 540: 536: 532: 525: 523: 521: 519: 515: 508: 506: 504: 500: 492: 490: 484: 482: 480: 477: 473: 465: 463: 461: 458: 454: 450: 446: 443: 439: 435: 431: 424:Neurotoxicity 423: 421: 419: 415: 411: 408: 404: 401: 398: 390: 388: 386: 382: 378: 374: 370: 356: 351: 347: 340: 331: 327: 320: 313: 309: 308: 306: 303: 298: 291: 289: 285: 258: 256: 252: 247: 240: 236: 235: 233: 231: 227: 220: 216: 215: 213: 211: 207: 200: 196: 195: 193: 191: 187: 180: 176: 175: 173: 171: 167: 160: 156: 155: 153: 151: 147: 140: 136: 135: 133: 126: 122: 115: 111: 110: 108: 106: 102: 93: 89: 82: 77: 70: 69: 67: 65: 61: 58: 55: 53: 49: 45: 41: 38:Clinical data 36: 32: 27: 19: 1405:Chloroarenes 1345:expanding it 1330: 1276: 1275: 1172: 1163:Fenfluramine 1145: 1081:Serotonergic 975: 939: 905:DOPA quinone 853: 834:Dopaminergic 768: 764: 757: 732: 728: 722: 697: 693: 687: 673:(1): 31–38. 670: 666: 660: 646:cite journal 619: 615: 609: 587:(1): 27–38. 584: 580: 530: 496: 488: 469: 457:dopaminergic 453:serotonergic 434:dopaminergic 427: 394: 372: 368: 367: 219:CHEBI:178132 18: 1284:Adrenergics 1168:Haloperidol 935:Haloperidol 885:Amphetamine 436:neurotoxin 397:dehydration 385:haloperidol 295: g·mol 114:125785-69-5 79:Identifiers 43:Other names 1384:Categories 1104:2,4,5-THMA 1003:Salsolinol 875:disulfiram 847:2,4,5-THMA 509:References 381:metabolite 300:3D model ( 288:Molar mass 239:ChEMBL1269 199:47Z7A2W953 170:ChemSpider 159:DBMET01212 105:CAS Number 88:IUPAC name 52:Drug class 1400:Alkanones 1277:See also: 1099:2,4,5-THA 1031:2,4,5-THA 842:2,4,5-THA 601:0731-3837 485:Discovery 440:(and its 1247:Unsorted 1071:Xylamine 998:Rotenone 993:Paraquat 950:Mancozeb 920:Dopamine 900:Dieldrin 679:10389142 638:26561842 499:reactive 150:DrugBank 64:ATC code 1134:5,7-DHT 1129:5,6-DHT 1114:3,4-DCA 1094:2,4-DCA 1051:DOPEGAL 1041:5,7-DHT 1036:5,6-DHT 895:Daidzin 890:Benomyl 873:(e.g., 861:5,6-DHT 785:1755839 749:1912294 714:2302206 460:neurons 428:HPP is 412:in the 410:enzymes 400:product 375:, is a 255:Formula 179:8151055 139:9975463 125:PubChem 1254:5-HIAL 783:  747:  712:  677:  636:  599:  545:  379:and a 326:SMILES 293:354.83 230:ChEMBL 1339:is a 1331:This 1264:RHPTP 1124:5-IAI 1056:DSP-4 1008:Ziram 955:Maneb 910:DOPAL 414:liver 407:CYP3A 405:, by 346:InChI 302:JSmol 210:ChEBI 1341:stub 1333:drug 1259:RHPP 1233:PCMA 1213:MMAI 1198:MDEA 1193:MDAI 1183:MBDB 1178:HPTP 1109:3-CA 970:MPTP 945:HPTP 781:PMID 745:PMID 710:PMID 675:PMID 652:link 634:PMID 597:ISSN 543:ISBN 503:RHPP 455:and 438:MPTP 403:HPTP 190:UNII 71:None 1238:PIA 1228:PCA 1223:PBA 1173:HPP 1158:DCA 1153:αET 940:HPP 773:doi 769:181 737:doi 702:doi 698:166 624:doi 589:doi 535:doi 445:MPP 387:. 383:of 369:HPP 129:CID 23:HPP 1386:: 1306:• 1302:• 1298:• 1294:• 1290:• 1286:• 1282:• 1144:α, 877:, 852:5- 779:. 767:. 743:. 731:. 708:. 696:. 671:51 669:. 648:}} 644:{{ 620:69 595:. 585:17 583:. 557:^ 541:. 517:^ 272:Cl 269:18 263:21 1372:e 1365:t 1358:v 1347:. 1146:N 976:N 881:) 854:S 818:e 811:t 804:v 787:. 775:: 751:. 739:: 733:4 716:. 704:: 681:. 654:) 640:. 626:: 603:. 591:: 551:. 537:: 304:) 281:O 278:N 275:F 266:H 260:C

Index


Drug class
Monoaminergic neurotoxin
ATC code
IUPAC name
CAS Number
125785-69-5
PubChem
9975463
DrugBank
DBMET01212
ChemSpider
8151055
UNII
47Z7A2W953
ChEBI
CHEBI:178132
ChEMBL
ChEMBL1269
Formula
Molar mass
JSmol
Interactive image
SMILES
InChI
monoaminergic neurotoxin
metabolite
haloperidol
dehydration
product

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.